These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7005587)

  • 1. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
    Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
    Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
    Dennler HJ; Bachmann H
    MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the practical use of mathematical methods and computer technics for the control of treatment with selected digitalis glycosides].
    Tytman B
    Pol Tyg Lek; 1981 Oct; 36(40):1553-5. PubMed ID: 7335534
    [No Abstract]   [Full Text] [Related]  

  • 5. DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
    Misurec J; Morávek Z; Náhunek K; Cesková E; Sláma B; Svestka J
    Act Nerv Super (Praha); 1978 Dec; 20(4):266-7. PubMed ID: 367038
    [No Abstract]   [Full Text] [Related]  

  • 6. Dihydroergocryptine in the management of senile psycho-organic syndrome.
    Scarzella L; Bono G; Bergamasco B
    Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
    Milvio C
    Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
    Trabant R; Poljakovic Z; Trabant D
    Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Time kinetics of effects of digitoxin and beta-acetyl digoxin following oral application in man (author's transl)].
    Belz GG; Czermak E; Belz G
    Z Kardiol; 1979 Feb; 68(2):77-81. PubMed ID: 371173
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
    Piguet PV; Zoufal Z
    Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
    Ronge J; Dennler HJ
    Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy with cardiac glycosides. Report of clinical experiences with a beta-acetyldigoxin preparation].
    Bouzo H; Weise HJ; Samman N; Munding M; Boeck K
    Med Welt; 1980; 31(46):1683-5. PubMed ID: 7453558
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
    Biel ML; Seus R; Struppler A
    Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
    Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled clinical study on beta-acetyldigoxin].
    Marsala F
    Clin Ter; 1984 Aug; 110(3):243-9. PubMed ID: 6237862
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
    Mailland F; Zottino G
    Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
    Kohler H
    Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons].
    Bagatin J; Rumboldt Z; Jurisić M; Vujić D
    Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydergine: a review of 26 clinical studies.
    McDonald RJ
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.